As of January 2026 Immunovant has a market cap of A$7.74 Billion. This makes Immunovant the world's 3051th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 12th, 2026 the market cap of Immunovant was reported to be: